Good work silentpartner. I also had a look at Gilead's website and verified your numbers.
Dont understand how Gilead can show a 27% increase in tamiflu royalty revenue on the December 09 quarter when Roche is showing a 50% decrease in sales for the same period. Is it an accounting issue?
Maybe volcanic ash is messing with spreadsheets over there.
Add to My Watchlist
What is My Watchlist?